Xceleron has partnered with Kinetigen, a clinical pharmacology consulting firm specializing in pharmacokinetics, to offer drug developers solutions for robust and cost-effective investigations of Phase I drug pharmacokinetics. Kinetigen will provide its complex PK analyses and overall clinical pharmacology strategies and Xceleron will use its Accelerator Mass Spectrometry (AMS) to gain analytical insight across a broad range of asset classes and matrix types.   “At Xceleron, we believe that tech...